Which innovative product launch strategy did Gilead Sciences use in 2014 that transformed access to their breakthrough hepatitis C medication Sovaldi, despite its $84,000 treatment cost?

The pharmaceutical and medical device industries have unique challenges when launching new products. Success depends on understanding regulatory hurdles, physician adoption patterns, and patient needs simultaneously. This poll tests your knowledge about one of the most significant medical product launch strategies that revolutionized patient access to critical medications.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

They introduced an income-based patient assistance program that covered up to 100% of costs for qualifying patients
They implemented a 'cure or your money back' guarantee to hospitals and insurers
They created a subscription model where healthcare systems paid a fixed annual fee for unlimited access
They launched with a direct-to-consumer financing plan allowing payments spread over 5 years